Cargando…

The Future of Lipid-Lowering Therapy

The recent introduction of inhibitors of proprotein convertase subtilisin/kexin 9 to lower low-density lipoprotein (LDL) cholesterol on top of statins or as monotherapy is rapidly changing the landscape of treatment of atherosclerotic cardiovascular disease (ASCVD). However, existing lipid-lowering...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Zwol, Willemien, Rimbert, Antoine, Kuivenhoven, Jan Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678580/ https://www.ncbi.nlm.nih.gov/pubmed/31340607 http://dx.doi.org/10.3390/jcm8071085

Ejemplares similares

Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
por: Visser, Jolien, et al.
Publicado: (2022)

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles
por: Zhang, Boyan, et al.
Publicado: (2021)

Use of plasma metabolomics to analyze phenotype-genotype relationships in young hypercholesterolemic females
por: Zhang, Xiang, et al.
Publicado: (2018)

Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
por: van Zwol, Willemien, et al.
Publicado: (2023)

Targeted Strategy in Lipid-Lowering Therapy
por: Dayar, Ezgi, et al.
Publicado: (2022)

Lipid-lowering therapy: who can benefit?
por: Lewis, Sandra J
Publicado: (2011)

Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates
por: Rimbert, Antoine, et al.
Publicado: (2022)

Antithrombotic therapy and bleeding risk in the era of aggressive lipid-lowering: current evidence, clinical implications, and future perspectives
por: Zhou, Xin, et al.
Publicado: (2023)

Role of Colesevelam in Combination Lipid-Lowering Therapy
por: Jones, Michael R., et al.
Publicado: (2013)

Lipid Lowering Therapy and Circulating PCSK9 Concentration
por: Nozue, Tsuyoshi
Publicado: (2017)

Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia
por: Hindi, Nagham N., et al.
Publicado: (2021)

Role of Lipid-Lowering Therapy in Peripheral Artery Disease
por: Belur, Agastya D., et al.
Publicado: (2022)

Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges
por: Gianazza, Erica, et al.
Publicado: (2023)

Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids
por: van der Graaf, Adriaan, et al.
Publicado: (2020)

Systematic Review: Evaluating the Effect of Lipid-Lowering Therapy on Lipoprotein and Lipid Values
por: Rosenson, Robert S., et al.
Publicado: (2013)

Lipids and Antiplatelet Therapy: Important Considerations and Future Perspectives
por: Đukanović, Nina, et al.
Publicado: (2021)

Lipid Lowering Drugs: Present Status and Future Developments
por: Ruscica, Massimiliano, et al.
Publicado: (2021)

Lipid-lowering interventions targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): an emerging chapter in lipid-lowering therapy
por: Kosmas, Constantine E, et al.
Publicado: (2017)

LDL lowering effect of PCSK9 inhibition is reduced in women
por: Myasoedova, Veronika A, et al.
Publicado: (2023)

Recycling the LDL receptor to combat atherosclerosis
por: Vos, Dyonne, et al.
Publicado: (2018)

PCSK9 inhibitors: A new era of lipid lowering therapy
por: Chaudhary, Rahul, et al.
Publicado: (2017)

Is there a role of lipid-lowering therapies in the management of fatty liver disease?
por: Tzanaki, Ismini, et al.
Publicado: (2022)

Small Interfering Ribonucleic Acid as Lipid-Lowering Therapy: Inclisiran in Focus
por: Rakocevic, Jelena, et al.
Publicado: (2023)

Bridging the Racial Disparity Gap in Lipid‐Lowering Therapy
por: Kalra, Dinesh K.
Publicado: (2020)

Lipid-lowering therapy in older persons
por: Aronow, Wilbert S.
Publicado: (2015)

Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
por: Sosnowska, Bożena, et al.
Publicado: (2022)

Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
por: Rossi, Maddalena, et al.
Publicado: (2021)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Forward Individualized Medicine from Personal Genomes to Interactomes
por: Zhang, Xiang, et al.
Publicado: (2015)

Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
por: Temporelli, Pier Luigi, et al.
Publicado: (2021)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
por: Desai, Nihar R., et al.
Publicado: (2022)

Effects of Lipid Lowering Therapies on Vulnerable Plaque Features: An Updated Narrative Review of the Literature
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2023)

Blood Pressure-Lowering Aspects of Lipid-Lowering and Anti-Diabetic Drugs
por: Nilsson, Peter M., et al.
Publicado: (2010)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
por: Alkhalil, Mohammad, et al.
Publicado: (2021)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Lipid Lowering Therapy to Modify Plaque Microstructures: Insights from Optical Coherence Tomography Imaging
por: Kataoka, Yu, et al.
Publicado: (2017)

Adherence to lipid-lowering treatment: the patient perspective
por: Casula, Manuela, et al.
Publicado: (2012)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
por: Cheung, Brian, et al.
Publicado: (2023)

Novel Uses for Lipid-Lowering Agents
por: May, Megan Brafford, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t5ckeckl61jbej24tov951jcku